Table: Surveillance rates of cefiderocol heteroresistance correlate with all-cause mortality in the APEKS-NP and CREDIBLE-CR trials CONCLUSION. These data suggest that the lower rates of cefiderocol HR in carbapenem-susceptible isolates that predominated the APEKS-NP trial may explain the enhanced ...
In effect, it gives the user of the model and simulation tools the decision-support insight that mirrors the formatted information familiar to them from a clinical trial cohort that addressed the range of variable parameters. Rule 4—list limitations explicitly Biomedical phenomena can be convoluted ...
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?doi:10.1016/S2666-5247(21)00271-8Jacob E.ChobyEmory Antibiotic Resistance Center, Atlanta, GA 30329, USA; Emory Vaccine Center, Atlanta, GA, USA.Tugba.Ozturk...